Diligence memo · auto-generated · as of July 2, 2026
Atomic Alchemy
Atomic Alchemy: limited disclosed financing to assess.
Diligence furtherNo decisive signal either way from the public record alone — the call needs primary diligence beyond the filings.
Businessfiled
Atomic Alchemy operates in Energy, based in Idaho Falls, ID, USA. We produce cancer-curing materials used in nuclear medicine.
Sub-sector tags: Hard Tech, Medical Devices, Small Modular Reactors, energy.
Capital & rounds (filed)filed
Atomic Alchemy has raised — in disclosed capital across 0 recorded rounds, aggregated from public filings.
Valuation (modeled)modeled
No modeled valuation — too little disclosed financing to estimate one.
Financing rhythm & timingmixed
Not enough dated financing history to read a financing rhythm.
Comparablesmixed
Capital scale ranks ahead of 54% of Energy peers (69 compared).
Modeled value ranks above 54% of those peers.
Risks & flagsmixed
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.